151 related articles for article (PubMed ID: 10864144)
1. Anti-inflammatory effect of FR140423, a novel selective cyclo-oxygenase-2 inhibitor, in rat adjuvant arthritis without gastrointestinal side effects.
Ochi T; Goto T
J Pharm Pharmacol; 2000 May; 52(5):553-60. PubMed ID: 10864144
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory activity of a novel selective cyclooxygenase-2 inhibitor, FR140423, on type II collagen-induced arthritis in Lewis rats.
Ochi T; Goto T
Prostaglandins Other Lipid Mediat; 2001 Dec; 66(4):317-27. PubMed ID: 11785783
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory and analgesic effects of a novel pyrazole derivative, FR140423.
Ochi T; Jobo-Magari K; Yonezawa A; Matsumori K; Fujii T
Eur J Pharmacol; 1999 Jan; 365(2-3):259-66. PubMed ID: 9988110
[TBL] [Abstract][Full Text] [Related]
4. The profile of FR140423, a novel anti-inflammatory compound, in yeast-induced rat hyperalgesia.
Ochi T; Fujii T; Motoyama Y; Goto T
Jpn J Pharmacol; 1999 Sep; 81(1):94-8. PubMed ID: 10580376
[TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory effect of FR188582, a highly selective inhibitor of cyclooxygenase-2, with an ulcerogenic sparing effect in rats.
Ochi T; Yamane-Sugiyama A; Ohkubo Y; Sakane K; Tanaka H
Jpn J Pharmacol; 2001 Feb; 85(2):175-82. PubMed ID: 11286400
[TBL] [Abstract][Full Text] [Related]
6. Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1J mice.
Ochi T; Ohkubo Y; Mutoh S
Biochem Pharmacol; 2003 Sep; 66(6):1055-60. PubMed ID: 12963493
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis.
Ochi T; Goto T
Br J Pharmacol; 2002 Feb; 135(3):782-8. PubMed ID: 11834626
[TBL] [Abstract][Full Text] [Related]
9. Selective cyclooxygenase-2 (COX-2) inhibitors reduce anti-Mycobacterium antibodies in adjuvant arthritic rats.
Turull A; Queralt J
Immunopharmacology; 2000 Jan; 46(1):71-7. PubMed ID: 10665781
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats.
Matsushita M; Masaki M; Yagi Y; Tanaka T; Wakitani K
Inflamm Res; 1997 Nov; 46(11):461-6. PubMed ID: 9427067
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.
Anderson GD; Hauser SD; McGarity KL; Bremer ME; Isakson PC; Gregory SA
J Clin Invest; 1996 Jun; 97(11):2672-9. PubMed ID: 8647962
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation.
Francischi JN; Chaves CT; Moura AC; Lima AS; Rocha OA; Ferreira-Alves DL; Bakhle YS
Br J Pharmacol; 2002 Nov; 137(6):837-44. PubMed ID: 12411415
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory activity of myricetin-3-O-beta-D-glucuronide and related compounds.
Hiermann A; Schramm HW; Laufer S
Inflamm Res; 1998 Nov; 47(11):421-7. PubMed ID: 9865500
[TBL] [Abstract][Full Text] [Related]
14. Effect of the COX-2 selective inhibitor l-745,337 on inflammation and organ prostaglandin E2 (PGE2) levels in adjuvant arthritic rats.
Turull N; Queralt J
Inflammation; 2000 Dec; 24(6):533-45. PubMed ID: 11128051
[TBL] [Abstract][Full Text] [Related]
15. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
16. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation.
Wallace JL; Chapman K; McKnight W
Br J Pharmacol; 1999 Mar; 126(5):1200-4. PubMed ID: 10205009
[TBL] [Abstract][Full Text] [Related]
17. Effects of non-steroidal anti-inflammatory drugs on rat gastric mucosal leukotriene C4 and prostanoid release: relation to ethanol-induced injury.
Peskar BM; Hoppe U; Lange K; Peskar BA
Br J Pharmacol; 1988 Apr; 93(4):937-43. PubMed ID: 3390662
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
19. Changes in prostaglandin E2 (PGE2) levels in paw exudate, stomach and kidney of arthritic rats: effects of flosulide.
Turull A; Queralt J
Prostaglandins Other Lipid Mediat; 2001 Aug; 66(1):27-37. PubMed ID: 11519792
[TBL] [Abstract][Full Text] [Related]
20. The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of lornoxicam in rats with paw inflammation.
Futaki N; Harada M; Sugimoto M; Hashimoto Y; Honma Y; Arai I; Nakaike S; Hoshi K
J Pharm Pharmacol; 2009 May; 61(5):607-14. PubMed ID: 19405999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]